Author： Kumar Gondi N. Jayanti Venkata K. Johnson Marianne K. Uchic John Thomas Samuel Lee Ronald D. Grabowski Brian A. Sham Hing L. Kempf Dale J. Denissen Jon F. Marsh Kennan C. Sun Eugene Roberts Stanley A.
Publisher： Springer Publishing Company
ISSN： 0724-8741
Source： Pharmaceutical Research, Vol.21, Iss.9, 2004-09, pp. : 1622-1630
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Lopinavir/ritonavir (ABT-378/r)
By Qazi Nadeem A Pozniak Anton L Morlese John F
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. :
Lopinavir/Ritonavir: A Review of its Use in the Management of HIV-1 Infection
By Croxtall Jamie D. Perry Caroline M.
Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. :
Darunavir + ritonavir superior to lopinavir/ritonavir for HIV infection
Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. :